Diabetes Research and Clinical Practice
Volume 83, Issue 2 , Pages 263-267 , February 2009

Cost of medical care among type 2 diabetic patients with a co-morbid condition—Hypertension in India

Received 14 April 2008 ,Revised 21 August 2008 ,Accepted 17 November 2008.

References 

  1. Gupta R. Trends in hypertension epidemiology in India, review article. J. Hum. Hypertens. 2004;18:73–78
  2. Mohan V, Deepa M, Deepa R, Shanthirani CS, Farooq S, Ganesan A, et al. Secular trends in the prevalence of diabetes and glucose tolerance in urban south India—The Chennai Urban Rural Epidemiology study (CURES 17). Diabetologia. 2006;49:1175–1178
  3. Kutty VR, Joseph A, Soman CR. High prevalence of type II diabetes in an urban settlement in Kerala, India. Ethn. Health. 1999;4:231–239
  4. Ramachandran A, et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001;44:1094–1101
  5. Mohan V, Deepa M, Farooq S, Datta M, Deepa R. Prevalence awareness and control of hypertension in Chennai CURES-52. JAPI. 2007;55:326–332
  6. Hypertension in Diabetic Study (HDS) . Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J. Hypertens. 1993;11:309–317
  7. Bhaskaran VP, Rau NR, Satyashankar , Ravi Raj A, Chinnappa S, Tarun K. A study of the direct cost incurred by type 2 diabetes mellitus patients for their treatment at a large tertiary-care hospital in Karnataka, India. J. Acad. Hosp. Admin. 2003;15:7–12
  8. The economics of diabetes and diabetes care. A report of the diabetes health economics study group, WHO and IDF, 1998, Diabetes Health Economics, IDF, 1999.
  9. W. Gruber, T. Lander, B. Leese, T. Songer, R. Williams, A report of the diabetes health economics study group, An IDF, WHO publication, the economics of diabetes and diabetes care, 1997.
  10. Rayappa PH, Raju KNM, Kapur A, Stefan B, Camilla S, Dilip Kumar KM. Economic costs of diabetes Care. The Bangalore Urban District diabetes study. Int. J. Diab. Dev. Countries. 1999;19:87–96
  11. A. Kapur, Cost of diabetes in India, The CODI study paper presented at the Novo Nordisk Diabetes update Bangalore, February 2000.
  12. Shobhana R, Rama Rao P, Lavanya A, Williams R, Vijay V, Ramachandran A. Expenditure on health care incurred by diabetic subjects in a developing country—a study from southern India. Diabetes Res. Clin. Pract. 2000;48:37–42
  13. Simpson SH, Corabian P, Jacobs P, Johnson JA. The cost of major co-morbidity in people with diabetes mellitus. Can. Med. Assoc. J. 2003;168:1661–1667
  14. Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care. 1997;20:1396–1402
  15. French MT, Mundt MP, Fleming M, Zavala SK. The cost of medical care for patients with diabetes, hypertension and both conditions: does alcohol use play a role?. J. Intern. Med. 2005;258:45–54
  16. WHO: Definition Diagnosis and Classification of Diabetes Mellitus and its Complications. Part I: Diagnosis and Classification of Diabetes Mellitus. Geneva: Dept. of Non Communicable Disease Surveillance, World Health Org; 1999;
  17. The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. The JNC 7 report, JAMA 289, 2003.
  18. Zhang P, Engelgau MM, Norris SL, Gregg EW, Venkat Narayan KM. Application of economic analysis to diabetes and diabetes care. Ann. Intern. Med. 2004;140:972–977
  19. Joshua AR, Valentine WJ, Secnik C. Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain. Curr. Med. Res. Opin. 2005;21:1617–1629
  20. Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in diabetes mellitus. Arch. Intern. Med. 1999;159:1873–1880
  21. Brien JAO, Shompe LA, Kavanagh PL, Raggio G, Caro JJ. Direct medical cost of complications resulting from type 2 diabetes in the U.S.. Diabetes Care. 1998;21:1122–1128
  22. Barry S, Robert EJ. Management of hypertension in diabetes. Diabetes Spectrum. 2006;19:25–31
  23. Stefan B, Kapur A, Camilla S, Dilip Kumar KM, Jyotsna N, Sanjeev K. In: Diabetes Care Organization and economics – the economic burden of diabetes in India – results from a national survey. Presentation made at Forum 9. Mumbai, India, September 12–16. 2005;
  24. Elliott WJ, Weir DR, Black HR. Cost effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensive patients. Arch. Intern. Med. 2000;160:1277–1283
  25. CDC Diabetes Cost-effectiveness Group. Cost effectiveness of intensive glycemic control, intensified hypertension control and serum cholesterol level reduction for type 2 diabetes. JAMA. 2002;287:2542–2551
  26. UKPDS 38 . Tight blood pressure control and risk of macro vascular and micro vascular complications in type 2 diabetes. BMJ. 1998;317:703–713

PII: S0168-8227(08)00583-4

doi: 10.1016/j.diabres.2008.11.027

Diabetes Research and Clinical Practice
Volume 83, Issue 2 , Pages 263-267 , February 2009

Article Tools

* Image Usage & Resolution